Shareholder Rights in the Methode Electronics Class Action: What You Need to Know
Robbins LLP has reminded investors about the opportunity to join the class action against Methode Electronics, Inc. (NYSE: MEI). The case covers all individuals and entities that purchased Methode’s common stock between June 23, 2022, and March 6, 2024. Methode designs and manufactures mechatronic products for Original Equipment Manufacturers (OEMs), and, during the period at issue, its shareholders found themselves facing a difficult stretch.
What the Complaint Says
According to the class action complaint, shareholders contend that Methode Electronics was not sufficiently transparent about its business outlook. The claims focus on alleged misstatements and omissions tied to problems at the company’s Monterrey facility and complications associated with transitioning away from the GM center console program.
Key Issues Flagged by Investors
The complaint points to several pressure points during a critical window. First, it alleges that Methode lost a significant number of skilled employees during the COVID-19 pandemic. That turnover, the filing says, undermined the company’s ability to move from a high-volume production model to a more complex, low-volume approach at its Monterrey site.
Second, the suit asserts that Methode’s push to diversify its production and pivot toward electric vehicle (EV) components ran into real-world hurdles. Shortfalls in production planning, inventory gaps, and vendor-related problems are cited as major obstacles—issues that, taken together, contributed to uneven execution of the company’s strategic shift.
How Those Allegations Tie to the Stock Price
The complaint alleges that these operational challenges left Methode’s stock trading at artificially inflated levels throughout the class period. After a series of corrective disclosures revealed adverse facts, the share price fell sharply—from a peak of more than $50 per share to less than $10 per share by mid-June 2024—an overall decline of more than 80%. For many investors, that drop translated into substantial losses.
Steps Shareholders Can Take Now
If you want to play a leading role in the case, time matters. Investors seeking appointment as lead plaintiff must submit applications to the court by the specified deadline. A lead plaintiff represents the class and helps guide the litigation. If you’d rather not take an active role, you can still remain in the class and be eligible for any recovery that may result from the case.
Robbins LLP’s Role
Robbins LLP has a long track record advocating for shareholder rights. Since 2002, the firm has focused on recovering losses for investors, holding executives to account, and improving corporate governance. To date, Robbins LLP reports recovering over $1 billion for shareholders, reflecting its experience in shareholder rights litigation.
Closing Thought
The class action against Methode Electronics, Inc. offers affected shareholders a path to be heard and, potentially, to recover losses. Participating also underscores a basic expectation in public markets: clear, candid communication with investors.
Frequently Asked Questions
What is the purpose of the class action against Methode Electronics?
The suit seeks to address alleged misleading statements and omissions about Methode’s business prospects, including issues at the Monterrey facility and the transition away from the GM center console program, which investors say affected the stock price.
Who can participate in the class action?
Any individual or entity that purchased Methode Electronics, Inc. common stock between June 23, 2022, and March 6, 2024, may be part of the class.
Do I have to serve as lead plaintiff to receive compensation?
No. Serving as lead plaintiff lets you represent the class and help direct the case, but you can choose not to seek that role and still remain eligible for any recovery as a class member.
What events are alleged to have driven the stock decline?
The complaint links the drop to corrective disclosures about operational problems. According to the filing, the stock fell from over $50 per share to less than $10 per share by mid-June 2024—more than an 80% decline.
How does Robbins LLP help, and what should I do if I want to participate?
Robbins LLP represents shareholders in pursuing recovery and improved governance. If you wish to participate, submit an application to the court before the deadline, and you may contact Robbins LLP for assistance and guidance.
